Search Results - "Delwar, Zahid"
-
1
Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3
Published in Cancer research (Chicago, Ill.) (01-02-2018)“…The first oncolytic virotherapy employing HSV-1 (oHSV-1) was approved recently by the FDA to treat cancer, but further improvements in efficacy are needed to…”
Get full text
Journal Article -
2
Tumour-specific triple-regulated oncolytic herpes virus to target glioma
Published in Oncotarget (10-05-2016)“…Oncolytic herpes simplex virus type 1 (oHSV-1) therapy is an emerging treatment modality that selectively destroys cancer. Here we report use of a glioma…”
Get full text
Journal Article -
3
Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes
Published in Biomedicines (09-11-2020)“…Oncolytic virotherapy is a promising new tool for cancer treatment, but direct lytic destruction of tumor cells is not sufficient and must be accompanied by…”
Get full text
Journal Article -
4
Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1
Published in Molecular therapy. Oncolytics (16-03-2023)“…VG2025 is a recombinant oncolytic herpes simplex virus type 1 (HSV-1) that uses transcriptional and translational dual regulation (TTDR) of critical viral…”
Get full text
Journal Article -
5
Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor
Published in Journal of cellular physiology (01-06-2016)“…It has long been realized that hematopoietic cells may have the capacity to trans‐differentiate into non‐lymphohematopoietic cells under specific conditions…”
Get full text
Journal Article -
6
Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells
Published in Vaccines (Basel) (01-12-2023)“…The development of effective cancer vaccines remains a significant challenge due to immune tolerance and limited clinical benefits. Oncolytic herpes simplex…”
Get full text
Journal Article -
7
Cytotoxic effect of menadione and sodium orthovanadate in combination on human glioma cells
Published in Investigational new drugs (01-08-2012)“…Summary Gliomas are the most common primary brain tumor, and their treatment is still a challenge. Here, we evaluated the antiproliferative effect of a novel…”
Get full text
Journal Article -
8
Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C
Published in Investigational new drugs (01-12-2011)“…Summary Menadione (Vitamin K3) has anti-tumoral effects against a wide range of cancer cells. Its potential toxicity to normal cells and narrow therapeutic…”
Get full text
Journal Article -
9
In vitro inhibition of topoisomerase IIα by reduced glutathione
Published in Acta biochimica Polonica (01-01-2011)“…In most cells, the major intracellular redox buffer is glutathione (GSH) and its disulfide-oxidized (GSSG) form. The GSH/GSSG system maintains the…”
Get full text
Journal Article -
10
Menadione : Sodium Orthovanadate Combination Eliminates and Inhibits Migration of Detached Cancer Cells
Published in ISRN pharmacology (2012)“…Exposure of cancer cells to anticancer agents in cultures induces detachment of cells that are usually considered dead. These drug-induced detached cells…”
Get full text
Journal Article -
11
A TRAMP‐derived orthotopic prostate syngeneic (TOPS) cancer model for investigating anti‐tumor treatments
Published in The Prostate (01-05-2018)“…Background Patients with advanced prostate cancer have limited curative options, therefore new treatments are needed. Mouse models play a pivotal role in the…”
Get full text
Journal Article -
12
Oncolytic virotherapy for urological cancers
Published in Nature reviews. Urology (01-06-2016)“…Key Points Oncolytic virotherapy is a cancer treatment that employs replication-competent viruses, which specifically infect, replicate in and lyse malignant…”
Get full text
Journal Article -
13
Abstract 5641: Synergy of immunomodulators delivered by an HSV-1 oncolytic virus can enhance its therapeutic effects in vivo
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Oncolytic HSV-1 (oHSV-1) are among the most promising therapies for cancer. Besides the oncolytic activity delivered by the virus against tumor cells, this…”
Get full text
Journal Article -
14
Abstract 5205: VG2025: Transcriptional and translational dually regulated (TTDR) oncolytic virus for cancer immunotherapy
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…VG2025 is a genetically modified HSV-1 oncolytic virus (OV) wherein the transcription and translation of critical viral genes are regulated to enhance virus…”
Get full text
Journal Article -
15
A comparative study of thyroid hormone levels in young diabetic and non-diabetic patients
Published in International journal of diabetes in developing countries (01-03-2014)“…Thyroid disorders can adversely affect diabetes control. The aim of the study was to compare thyroid hormone levels in type 1 diabetic patients with that of…”
Get full text
Journal Article -
16
The Stemness Phenotype Model
Published in ISRN oncology (2012)“…The identification of a fraction of cancer stem cells (CSCs) associated with resistance to chemotherapy in most solid tumors leads to the dogma that…”
Get full text
Journal Article